Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Cancer Research Ventures Ltd. engages in the business of research and experimental development on biotechnology. It provides medical products. The company is headquartered in London, the United Kingdom.

Nanjing Drum Tower Hospital is a private company headquartered in China. The firm provides medical services.

Zhiben Medical Technology (Shanghai) Co. Ltd. (doing business as OrigiMed) is a company headquartered in Shanghai, China. The firm develops medical science and technology transforming application. It was founded in 2016.\nThe company says this about itself: OrigiMed is a precision medicine company focusing on high-tech R&D with a global vision and the knowledge transfer in the clinical practice of cancers. With the commitment to developing hundreds of cancer genomic tests, the company strive to provide comprehensive and accurate molecular information to every patient and help doctors with their precision medicine practice. OrigiMed aims to promote the innovation in the way of clinical treatment for cancer in China. At OrigiMed, patients' molecular changes are identified by the stringently verified CGP and matched with approved targeted therapies, immunotherapies, and clinical trials. OrigiMed closely collaborates with global and domestic biopharmaceutical companies to help with new drug development and approvals.

CAVΛDIS™ is a Dutch biomedical company active in the field of cardiovascular risk assessment. They develop prognostic tests to identify patients at risk of cardiovascular and disease. The company identified several novel biomarkers predictive for cardiovascular events. It is their goal is to develop clinically meaningful risk stratification tools that will help personalize treatment and achieve better patient outcomes.

Hefei Tongmian Biotechnology Co., Ltd., established on 2015-03-05, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);Development of Human Gene Diagnosis and Therapy Technology;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;R&D and application of cell technology;Health Consulting Services(Does not include medical services);Import and export(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Inspection and testing service;Disinfectant production(Free of Hazardous Chemicals);Disinfection equipment sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Novomics develops cancer treatment-linked diagnosis systems based on its expertise and knowledge in the field of molecular diagnosis. A significant strength of Novomics is its network of specialists and clinicians, as well as the knowledge gains made possible by technological advancements in the age of precision medicine. By embracing cutting-edge clinical, molecular biological, and academic achievements and forming close collaborative relationships with pharmaceutical companies and hospitals that are significant players in the medical industry.

Quest Diagnostics Investments LLC, a subsidiary of Quest Diagnostics, Inc., is an American company specializing in medical laboratories.

Nippon Menard Cosmetic Co. Ltd. develops cosmetic and health products. They manufacture and distributes cosmetics such as make-ups and perfumes, and also health food, and undergarments. The company was established in November 11, 1959 and is based in Aichi, Japan.

Nanjing Gulou Hospital is a Chinese private company located in Nanjing. The firm operates as a hospital.